Stock MDG1 MEDIGENE AG
Add to a list
To use this feature you must be a member
Log inSign up

News Medigene AG

Equities

MDG1

DE000A1X3W00

Market Closed - Xetra
Other stock markets
 11:36:07 2024-05-10 am EDT 		5-day change 1st Jan Change
1.44 EUR 0.00% Intraday chart for Medigene AG -6.80% -5.57%
May. 08 Medigene Boosts Share Capital Via Rights Offering, Private Placement MT
May. 02 Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 - Targeted T Cell Receptor CI

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Medigene Boosts Share Capital Via Rights Offering, Private Placement
MT
Medigene to Present at Upcoming Conferences
GL
Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 targeted T Cell Receptor
AQ
Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 – targeted T Cell Receptor
GL
Medigene AG Expands Patent Portfolio with European Patent Grant for its NY-ESO-1 - Targeted T Cell Receptor
CI
Medigene Presents Superior TCR-T Cell Functionality by Inclusion of a Costimulatory Switch Protein
GL
Medigene Presents Superior TCR-T Cell Functionality by Inclusion of A Costimulatory Switch Protein
CI
Medigene : Quartely Statement 2024
PU
Medigene AG reports Financial Results and Business Update for Q1 2024
GL
Medigene presents streamlined 6-day, high stemness TCR-T therapy production process
GL
Medigene AG Presents Streamlined 6-Day, High Stemness Tcr-T Therapy Production Process
CI
Rights Issue: 1 new share @ 1.2 EUR for 5 existing shares
FA
Medigene to Present at Upcoming Scientific Conferences
GL
Medigene Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024
GL
Medigene AG Presents Favorable Safety Profile of TCR-T Cells with Costimulatory Switch Protein at AACR Annual Meeting 2024
CI
Medigene Gets European Patent for T-Cell Receptor Technology
MT
Medigene AG Secures European Patent for its iM-TCR Technology
GL
Medigene AG Secures European Patent for Its iM-TCR Technology
CI
Medigene AG Reports Earnings Results for the Full Year Ended December 31, 2023
CI
Transcript : Medigene AG, 2023 Earnings Call, Mar 28, 2024
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. MDG1 Stock
  4. News Medigene AG
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW